Therapy Switching, Augmentation, and Discontinuation in Patients with Osteoarthritis and Chronic Low Back Pain

Background:  Recommended pain treatments for osteoarthritis (OA) and chronic low back pain (CLBP) are suboptimal, and limited information is available regarding patterns of pharmacotherapy among patients with these conditions.

[1]  M. Tryba,et al.  Meta-analysis of dropout rates in randomized controlled clinical trials , 2011, Der Schmerz.

[2]  R. Chou.  Pharmacological Management of Low Back Pain , 2010, Drugs.

[3]  J. Dunn,et al.  A claims-based view of health care charges and utilization for commercially insured patients with osteoarthritis. , 2009, Managed care.

[4]  R. Bitton.  The economic burden of osteoarthritis. , 2009, The American journal of managed care.

[5]  D. Hunter.  Imaging insights on the epidemiology and pathophysiology of osteoarthritis. , 2009, Rheumatic diseases clinics of North America.

[6]  Á. Lanas,et al.  Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use , 2009, BMC gastroenterology.

[7]  Chan Kw,et al.  Co-morbidities of patients with knee osteoarthritis. , 2009 .

[8]  C. Maher,et al.  A systematic review of paracetamol for non-specific low back pain , 2008, European Spine Journal.

[9]  Alan G. White,et al.  Direct and Indirect Costs of Pain Therapy for Osteoarthritis in an Insured Population in the United States , 2008, Journal of occupational and environmental medicine.

[10]  I. Boutron,et al.  Disability and quality of life of patients with knee or hip osteoarthritis in the primary care setting and factors associated with general practitioners' indication for prosthetic replacement within 1 year. , 2008, Osteoarthritis and cartilage.

[11]  F. Schellevis,et al.  Comorbidity, limitations in activities and pain in patients with osteoarthritis of the hip or knee , 2008, BMC musculoskeletal disorders.

[12]  Philip G Conaghan,et al.  Care and management of osteoarthritis in adults: summary of NICE guidance , 2008, BMJ : British Medical Journal.

[13]  P Tugwell,et al.  OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. , 2008, Osteoarthritis and cartilage.

[14]  S. Gabriel,et al.  Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. , 2008, Arthritis and rheumatism.

[15]  G. Joshi,et al.  Cardiovascular Thromboembolic Adverse Effects Associated with Cyclooxygenase-2 Selective Inhibitors and Nonselective Antiinflammatory Drugs , 2007, Anesthesia and analgesia.

[16]  Roger Chou,et al.  Medications for Acute and Chronic Low Back Pain: A Review of the Evidence for an American Pain Society/American College of Physicians Clinical Practice Guideline , 2007, Annals of Internal Medicine.

[17]  P Tugwell,et al.  OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. , 2007, Osteoarthritis and cartilage.

[18]  M. Dougados,et al.  Efficacy and safety of opioids for osteoarthritis: a meta-analysis of randomized controlled trials. , 2007, Osteoarthritis and cartilage.

[19]  C. Eccleston,et al.  Concerns about medication and medication use in chronic pain. , 2006, The journal of pain : official journal of the American Pain Society.

[20]  M. Fleming,et al.  Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain , 2006, Current medical research and opinion.

[21]  J Lyle Bootman,et al.  Value in health care. , 2006, Managed care interface.

[22]  J. Reginster,et al.  Direct and indirect costs attributable to osteoarthritis in active subjects. , 2006, The Journal of rheumatology.

[23]  G. Pransky,et al.  Worker productivity loss associated with arthritis. , 2006, Disease management : DM.

[24]  G. Hawker,et al.  The economic burden of disabling hip and knee osteoarthritis (OA) from the perspective of individuals living with this condition. , 2005, Rheumatology.

[25]  K. Stockl,et al.  Gastrointestinal Bleeding Rates Among Managed Care Patients Newly Started on COX-2 Inhibitors or Nonselective NSAIDs , 2005, Journal of managed care pharmacy : JMCP.

[26]  F. Salaffi,et al.  Health-related quality of life in patients with hip or knee osteoarthritis: comparison of generic and disease-specific instruments , 2005, Clinical Rheumatology.

[27]  F. Salaffi,et al.  Direct and indirect costs of osteoarthritis of the knee. , 2004, Clinical and experimental rheumatology.

[28]  F. Ahern,et al.  Health-related quality of life and health service use among older adults with osteoarthritis. , 2004, Arthritis and rheumatism.

[29]  R. Makuch,et al.  Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX‐2 specific inhibitors and non‐specific NSAIDs , 2004, Pharmacoepidemiology and drug safety.

[30]  Ricardo Pietrobon,et al.  Estimates and Patterns of Direct Health Care Expenditures Among Individuals With Back Pain in the United States , 2004, Spine.

[31]  Arden,et al.  EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) , 2003, Annals of the rheumatic diseases.

[32]  D. Uebelhart,et al.  Rofecoxib improves quality of life in patients with hip or knee osteoarthritis. , 2002, Swiss medical weekly.

[33]  J. Thornby,et al.  Physicians' Attitudes Toward Pain and the Use of Opioid Analgesics: Results of a Survey from the Texas Cancer Pain Initiative , 2000, Southern medical journal.

[34]  G. Andersson.  Epidemiological features of chronic low-back pain , 1999, The Lancet.

[35]  F. Keefe,et al.  Psychosocial assessment of pain in patients having rheumatic diseases. , 1999, Rheumatic diseases clinics of North America.

[36]  A. Silman,et al.  Outcome of low back pain in general practice: a prospective study , 1998, BMJ.

[37]  R. Dertwinkel,et al.  Experiences with the prescription of opioids: a patient questionnaire. , 1998, Journal of pain and symptom management.

[38]  W M O'Fallon,et al.  Direct medical costs unique to people with arthritis. , 1997, The Journal of rheumatology.

[39]  P. Hansten,et al.  Nonsteroidal antiinflammatory drug discontinuation in patients with osteoarthritis. , 1995, The Journal of rheumatology.

[40]  R. Deyo,et al.  Physician Office Visits for Low Back Pain: Frequency, Clinical Evaluation, and Treatment Patterns From a U.S. National Survey , 1995, Spine.

[41]  J. Coste,et al.  Clinical course and prognostic factors in acute low back pain: an inception cohort study in primary care practice , 1994, BMJ.

[42]  B. Walker,et al.  CHRONIC LOW BACK PAIN , 1992, COMSIG review.

[43]  H. Kraus,et al.  Diagnosis and treatment of low back pain. , 1952, GP.

[44]  J. Caro,et al.  A systematic review of low back pain cost of illness studies in the United States and internationally. , 2008, The spine journal : official journal of the North American Spine Society.

[45]  Atlanta,et al.  Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. , 2008, Arthritis and rheumatism.

[46]  A. Woolf,et al.  Burden of major musculoskeletal conditions. , 2003, Bulletin of the World Health Organization.

[47]  T. Schnitzer,et al.  Recommendations for the Medical Management of Osteoarthrits of the Hip and Knee , 2002 .

[48]  Thomas J. Schnitzer,et al.  Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update , 2000 .

[49]  T. Rosemann,et al.  Journal of Orthopaedic Surgery and Research Open Access Osteoarthritis: Quality of Life, Comorbidities, Medication and Health Service Utilization Assessed in a Large Sample of Primary Care Patients , 2022 .